Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Finished Goods: 2012-2014

Historic Finished Goods for Tenax Therapeutics (TENX) over the last 2 years, with Jan 2014 value amounting to $68,658.

  • Tenax Therapeutics' Finished Goods fell 13.27% to $68,658 in Q1 2014 from the same period last year, while for Jan 2014 it was $68,658, marking a year-over-year decrease of 13.27%. This contributed to the annual value of $70,425 for FY2013, which is 21.86% up from last year.
  • As of Q1 2014, Tenax Therapeutics' Finished Goods stood at $68,658, which was down 0.79% from $69,206 recorded in Q4 2013.
  • Over the past 5 years, Tenax Therapeutics' Finished Goods peaked at $80,578 during Q4 2012, and registered a low of $49,480 during Q3 2012.
  • In the last 3 years, Tenax Therapeutics' Finished Goods had a median value of $69,682 in 2013 and averaged $68,182.
  • Within the past 5 years, the most significant YoY rise in Tenax Therapeutics' Finished Goods was 41.79% (2013), while the steepest drop was 14.11% (2013).
  • Quarterly analysis of 3 years shows Tenax Therapeutics' Finished Goods stood at $80,578 in 2012, then fell by 14.11% to $69,206 in 2013, then dropped by 13.27% to $68,658 in 2014.
  • Its Finished Goods stands at $68,658 for Q1 2014, versus $69,206 for Q4 2013 and $70,157 for Q3 2013.